Interpace Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2014 | $95.8M | $115.2M | $23.1M |
| FY2015 | $54.7M | $64.7M | $8.3M |
| FY2016 | $35.2M | $25.1M | $602.0K |
| FY2017 | $13.7M | $36.6M | $15.2M |
| FY2018 | $15.7M | $31.1M | $6.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2014 | $95.8M | $115.2M | $23.1M |
| FY2015 | $54.7M | $64.7M | $8.3M |
| FY2016 | $35.2M | $25.1M | $602.0K |
| FY2017 | $13.7M | $36.6M | $15.2M |
| FY2018 | $15.7M | $31.1M | $6.1M |